Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Hemispherx BioPharma Company Profile (NYSE:HEB)

Consensus Ratings for Hemispherx BioPharma (NYSE:HEB) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00 (1,046.35% upside)

Analysts' Ratings History for Hemispherx BioPharma (NYSE:HEB)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/21/2014Chardan CapitalInitiated CoverageBuy$3.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/27/2012 forward)